Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In
  • Log Out

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
  • Log Out
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on RSS
Research ArticleArticle

Cartilage Destruction Is Partly Induced by the Internal Proteolytic Enzymes and Apoptotic Phenomenon of Chondrocytes in Relapsing Polychondritis

NAOHISA OUCHI, MIWA UZUKI, AKIHISA KAMATAKI, YASUHIRO MIURA and TAKASHI SAWAI
The Journal of Rheumatology April 2011, 38 (4) 730-737; DOI: https://doi.org/10.3899/jrheum.101044
NAOHISA OUCHI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MIWA UZUKI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AKIHISA KAMATAKI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YASUHIRO MIURA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKASHI SAWAI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tsawai@iwate-med.ac.jp
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

Abstract

Objective. We analyzed 9 cases by immunohistochemical studies in order to elucidate the mechanisms of cartilage destruction in relapsing polychondritis (RP), which often involves the external auricle and respiratory tract through immunological disorder.

Methods. Cartilage tissues were obtained during surgical operations. Cell species in the granulation tissues, especially near the cartilage, were identified by cell-surface markers [CD3, CD4, CD8, CD20, CD45 (LCA), and CD68]. The proteolytic enzymes expressed in the cells in the perichondral granulation and in chondrocytes themselves were analyzed by immunohistochemical studies using anti-matrix metalloproteinase (MMP) -1, -3, -8, -9, and -13, and cathepsin D, K, L, and elastase antibodies. Apoptosis and nitric oxide (NO), an apoptosis-related factor, were also examined using ApopTag and antinitrotyrosine antibody, respectively.

Results. Among cell species that infiltrated in perichondral granulation, LCA, CD68 (monocytes/macrophages), and CD4 cells were dominant in number; MMP-8, MMP-9, and elastase were expressed only in the perichondral granulation; whereas MMP-3 and cathepsin K and L were detected in both chondrocytes and granulations. Out of 9 cases examined, 6 revealed apoptotic cells in excess of 50% of chondrocytes. There was a strong correlation between the number of apoptotic cells and the number of MMP-3-positive (r = 0.83) and cathepsin K-positive cells (r = 0.92). Abundant NO-expressing cells were observed in the chondrocytes in degenerated cartilage, similar to apoptosis.

Conclusion. Cartilage destruction in polychondritis is induced not only by perichondral inflammation, but also by intrinsic factors expressed in chondrocytes themselves, including certain kinds of proteolytic enzymes and apoptosis.

Key Indexing Terms:
  • RELAPSING POLYCHONDRITIS
  • CARTILAGE
  • GRANULATION
  • APOPTOSIS

Relapsing polychondritis (RP) is a rare disease characterized by inflammation of the systemic cartilage tissues and a pattern of repeated remission and recurrence. The chondritis appears in the external auricle, the nose, the respiratory tract, and joints1. In addition, inflammation also involves organs consisting of certain kinds of proteoglycans such as the eye2, heart3, and inner ear4. Among these, the most common clinical manifestation is auricular chondritis5. Subsequent loss of the auricular cartilage may result in a floppy appearance or cauliflower ear. The most serious complication of RP is involvement of the cartilage of the respiratory tract6. In severe cases, there may be extensive inflammation and edema of the laryngeal cartilage and tracheal cartilage, causing narrowing of the airways7. The 5- and 10-year probabilities for survival after diagnosis of relapsing polychondritis are 74% and 55%, respectively8. The most widely used diagnostic criteria are those established by McAdam, et al in 19761 and modified by Damiani, et al in 19799. The pathogenesis of RP is unknown, but it has been suggested that it is a form of autoimmune disease10. Approximately 30% of patients with RP exhibit complications characteristic of autoimmune disease, including rheumatoid arthritis (RA)11, systemic lupus erythematosus12, anticardiolipin antibody syndrome13, and Sjögren’s syndrome14. Type II, IX, and XI collagens and matrilin-1, a cartilage matrix protein, were suggested as antigens15,16,17. Cells responsible for cartilage destruction in ear lesions are neutrophils, lymphocytes, monocytes/macrophages, and plasma cells in perichondral granulation. These infiltrate the tissues adjacent to the cartilage and cause diffuse basophilic loss suggesting depletion of proteoglycan from cartilage. However, precise cytochemical analysis of cells involved in the destruction of cartilage in RP has not been reported.

In order to elucidate the mechanisms of cartilage destruction in polychondritis, we carried out immunohistochemical analysis of the inflammatory cell species comprising granulation tissues, especially near the cartilage, and of the expression of proteolytic enzymes contained in cells in perichondral granulation and in chondrocytes themselves. We also examined the expression of apoptosis of chondrocytes, recently suggested as an important factor in cartilage destruction, by TUNEL assay (terminal deoxynucleotide transferase-mediated dUTP nick end-labeling).

MATERIALS AND METHODS

Samples

Cartilage tissues of 7 external auricles and 2 respiratory tracts were obtained from 8 patients with RP as defined by the McAdam or Damiani-modified criteria. Tissues were taken with the consent of the patients. The tissues were fixed in 4% paraformaldehyde in phosphate buffered saline solution (PBS) for 24 h, and then embedded in paraffin. Sections 3-μm thick were prepared and stored until use.

Hematoxylin-eosin stain and toluidine blue

Two sections were subjected to hematoxylin-eosin (HE) staining and toluidine blue staining for ordinary observation and demonstration of proteoglycan depletion from cartilage.

Immunohistochemistry and histochemistry

Immunohistochemical study was performed using paraffin sections. Antibodies used were as follows: monoclonal antibodies to CD3 (Nichirei, Tokyo, Japan), CD4 (Nichirei), CD8 (Nichirei), CD20 (Nichirei), CD68 (Dako, Glostrup, Denmark), LCA (Nichirei), MMP-1 (Kanebo, Tokyo, Japan), MMP-8 (Fuji Chemical, Tokyo, Japan), and MMP-9 (Kanebo); polyclonal antibodies to MMP-3 (Kirkinenn, et al) and elastase (Leica Microsystems, Wetzlar, Germany) produced in sheep, and to MMP-13 (Fuji Chemical), cathepsin D (Leica Microsystems), cathepsin L (Santa Cruz Biotechnology, Santa Cruz, CA, USA), nitrotyrosine (Upstate Biotechnology, Lake Placid, NY, USA), IgG (Dako) and IgM (Dako) produced in rabbit, and goat anti-cathepsin K (Santa Cruz Biotechnology). Nitric oxide (NO)-related apoptosis was demonstrated by immunohistochemistry using antinitrotyrosine antibody. Immunohistochemical procedures were as follows. After deparaffinization in xylene and in 100% ethanol, sections were treated with 1% hydrogen peroxide in methanol for 30 min, followed by rinsing with PBS for 15 min. They were covered with 10% normal rabbit serum (CD3, CD4, CD8, CD20, CD68, LCA, MMP-8, and elastase), 10% normal horse serum (MMP-1, MMP-9, and cathepsin K), and 10% normal goat serum (MMP-13, cathepsin L, IgG and IgM) in PBS for 30 min at room temperature. The excess normal serum was removed and the sections were covered with the primary antibodies overnight at 4°C. After 24 h the sections were rinsed with PBS and covered with the secondary antibodies for 30 min at room temperature. The sections were then covered with avidin-biotin-antiperoxidase (MMP-1, -3, -9, cathepsin K, and elastase) or streptavidin-biotin-antiperoxidase (CD3, CD4, CD8, CD20, CD68, LCA, IgG, IgM, MMP-8, MMP-13, cathepsin D and cathepsin L) for 30 min at room temperature and rinsed in PBS. Antigenic sites on sections were exposed to 3-3′ diaminobenzidine tetrahydrochloride and counterstained with methyl green. The number of inflammatory cells positive for each CD antigen was counted per 400-mm2 area in 20 microscopic fields of perichondral regions. The positive cells of each proteolytic enzyme were also counted and compared by number. NO was demonstrated by application of the microwave method using rabbit antinitrotyrosine antibody. NO-related apoptosis was demonstrated by immunohistochemistry using antinitrotyrosine antibody.

TUNEL assay

The sections were deparaffinized in xylene followed by 100% ethanol, then permeated with 20 μg/ml of proteinase K for 15 min, and incubated with terminal deoxynucleotidyl transferase (TdT) enzyme and reaction buffer (ApopTag kit, InterGen, Purchase, NY, USA) for 60 min at 37°C. They were then covered with antidigoxigenin peroxidase for 30 min at room temperature, exposed to 3-3′ diaminobenzidine tetrahydrochloride, and counterstained with methyl green.

The number of chondrocytes undergoing apoptosis in 400-mm2 areas in 20 randomly-chosen fields was counted, and the mean number of positive cells per field was calculated. The relationship between the number of apoptotic cells and positive cells expressing proteolytic enzymes such as MMP-3 and cathepsin K was then examined.

RESULTS

Patients

Out of 8 cases meeting the McAdam or Damiani-modified criteria for polychondritis, 4 were male and 4 were female, ranging in age from 34 to 80 years, with an average age of 65.1 years.

Histopathology of cartilage and granulation around the cartilage

The histopathology was highly characteristic of relapsing polychondritis. Acidophilic (pink) coloration of the cartilage matrix with proteoglycan-depleted cartilage [in contrast to the basophilic (blue) hue of normal cartilage] was seen by routine hematoxylin and eosin staining (Figure 1a). Focal or diffuse infiltration by predominantly mononuclear inflammatory cells, with occasional polymorphonuclear leukocytes and plasma cells in the perichondral tissues, was associated with dissolution of cartilage from its periphery inward (Figure 1b). Fibroblastic granulation tissue frequently coexists and leads to partial sequestration of the cartilage matrix. There was no evidence of necrotizing angiitis or thrombosis.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Histological feature of polychondritis of the left auricle. Granulation tissues coexist with partial sequestration of cartilage matrix (a; H&E stain, original magnification ×6.6). Acidophilic (pink) coloration of degenerated cartilage (b). Infiltration of inflammatory cells composed of mononuclear inflammatory cells with occasional polymorphonuclear leukocytes and plasma cells in perichondral tissues (H&E stain, original magnification ×33).

Cell features

Immunohistochemical staining revealed that LCA-positive cells including macrophages/monocytes, granulocytes, and lymphocytes infiltrated diffusely in the granulation tissue around the cartilage. Among the inflammatory cells, LCA-, CD68-, CD3-, and CD4-positive cells were dominant. Related to CD3-positive T lymphocytes, CD4-positive cells comprising lymphocytes (helper) and histiocytic cells increased significantly, while CD8-positive (cytotoxic) lymphocytes were less abundant (Figures 2 and 3).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Panel of inflammatory cells in perichondritis, in the perichondral region, demonstrated by immunohistochemistry. LCA-positive (a), CD68-positive (b), and CD4-positive cells (c) were abundant compared with CD8+ and CD20+ (d). (Immunohistochemistry; a, original magnification ×6.6; b, c, d ×13.2.)

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Comparison of inflammatory cells in perichondral granulation tissue. CD68+ and CD4+ cells were dominant compared with CD20+ and CD8+ cells.

Expression of proteolytic enzymes in perichondral granulation and cartilage

MMP-1 was present in perichondral granulation tissue and less so in chondrocytes. MMP-3 was diffusely expressed from pericellular regions to matrix in cartilage, but not so conspicuous in perichondral granulation. MMP-8 was only present in granulocytes in perichondral granulation. MMP-9 was present in granulocytes and spindle cells in perichondral granulation, and was not present in cartilage. Limited presence of MMP-13 was noted both in chondrocytes and in perichondral granulation. Cathepsins D, K, and in particular L were expressed both in chondrocytes and in perichondral granulation. Elastase was present only in perichondral granulation tissue. From these expression patterns, proteolytic enzymes expressed in RP were divided into 3 groups: the first group of enzymes such as MMP-9, MMP-8, and elastase was expressed only in the perichondral granulation and was not seen in cartilage; the second group was moderately present in both chondrocytes and perichondral granulation; the third group comprised enzymes such as cathepsins K and L, which were expressed abundantly in chondrocytes, although detected both in cartilage and in perichondral regions (Figure 4). The ratio of MMP and other proteo lytic enzymes in and around the deteriorated cartilage is shown in Figure 5.

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Panel of proteolytic enzymes in cartilage. MMP-3 (a, b), cathepsin K (e, f), and cathepsin L (g, h) were expressed in cytoplasm of chondrocytes and granulation tissues around the cartilage. MMP-9 (c, d), however, was not detected in chondrocytes in any severe inflammatory conditions (b, d). (Immunohistochemistry; a, c, e, g, original magnification ×13.2; d, ×33; b, f, h, ×66).

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Comparison of proteolytic enzymes in cartilage and perichondral granulation demonstrated by immunohistochemistry. MMP-1, 8, and 9 and cathepsins D, K, and L were abundantly expressed in the perichondral region, whereas MMP-3 and cathepsin K and L were prominent in cartilage. Among proteolytic enzymes, MMP-9 and MMP-8 were expressed only in inflammatory cells in perichondral granulation and never in chondrocytes.

Expression of apoptotic phenomenon in chondrocytes

Out of 9 cases in which the expression of apoptosis in chondrocytes was examined by TUNEL assay, 6 cases showed a significant apoptotic phenomenon in polychondritis (Figure 6). The ratio of TUNEL-positive cells to all chondrocytes counted was from 15% to 98%, with a mean of 61.7% (Table 1). Positive cells were more prominent in the peripheral region than in the inner region of deteriorating cartilage.

Figure 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6.

Apoptosis of chondrocytes related to cartilage degeneration demonstrated by TUNEL assay. Many apoptotic cells were detected in RP chondrocytes although the grade of expression differed between cases (ApopTag; original magnification ×33).

View this table:
  • View inline
  • View popup
Table 1.

Ratio of apoptotic cells to total chondrocytes. Apoptotic chondrocytes as a percentage of total chondrocytes in deteriorated cartilage ranged from 15% to 98% (average 61.7%). Six in 9 cases of relapsing polychondritis revealed more than 50% apoptotic cells.

Correlation between the apoptotic phenomenon and expression of proteolytic enzymes

There was a significant positive correlation between the number of apoptotic cells and MMP-3 (r = 0.86) and cathepsin K (r = 0.92), respectively, in cartilage (Figures 7 and 8).

Figure 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 7.

A strong positive correlation was shown between the number of apoptotic cells and MMP-3-positive cells (r = 0.86).

Figure 8.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 8.

A strong positive correlation was shown between the number of apoptotic cells and cathepsin K-positive cells (r = 0.92).

Correlation between the apoptotic phenomenon and expression of nitric oxide

NO was present in many chondrocytes in deteriorated cartilage (Figure 9).

Figure 9.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 9.

Nitric oxide was expressed in many chondrocytes in deteriorated cartilage. (Immunohistochemistry; original magnification ×33.)

DISCUSSION

Relapsing polychondritis is complicated by various diseases, in particular by autoimmune diseases such as arthritis18, vasculitis19, conjunctivitis20, cardiac valvular disorder21, and certain autoimmune-associated diseases such as myelodysplastic disease22. The etiology of RP is still unknown, but hypergammaglobulinemia, especially anti-type II, type IX15,16, and matrilin-1 antibodies17, has been reported in some patients. IgG concentration in our cases was fairly high, from 2394 to 2930 mg/dl (mean 2826.5 ± 129.2 mg/dl). However, only one case showed slight elevation of anti-type II collagen antibody. It was reported that the titer of anti-type II collagen antibody was high only at disease onset and not at the time of disease flare23. We did not detect any relationship between the immunoglobulin deposits in the inflamed tissues and cartilage destruction (data not shown), which may partly account for the duration of illness and the inflammatory stage.

Immunohistochemical staining showed many LCA-positive cells infiltrated in the granulation around the cartilage. In addition, CD68-positive cells were significantly increased. In more distant surrounding tissues, CD3-positive cells, CD4-positive lymphocytes (helper), and spindle cells were significantly increased, while CD8- and CD20-positive cells and cytotoxic lymphocytes were not found in large numbers (Figure 3). Compared with the synovial tissues of RA, LCA- and CD68-positive cells were similarly prominent, and CD4- and CD8-positive cells less prominent. In RA synovial tissues, CD68- and CD4-positive cells, including spindle-shaped histiocytic cells, are the major cellular components associated with the cartilage and bone destruction, together with chondroclasts and osteoclasts, and express MMP-9 and cathepsin D, K, and L. Therefore, it is suggested that similar cells in RP may function in cartilage and bone destruction. The histological characteristics of cell features differ from the synovial tissues, which are characterized by significant lymphocytic infiltration, but are similar to the granulation tissue called pannus, which plays an important role in destruction of cartilage and bone in RA. The MMP family consists of collagen-degrading enzymes including the collagenases (MMP-1, MMP-8, MMP-13), gelatinase A (MMP-2), gelatinase B (MMP-9), stromelysin (MMP-3), and a membrane-type MMP (MMP-14). Cathepsin D, K, and L and elastase are also able to degrade cartilage in RA and osteoarthritis (OA). We demonstrated that many kinds of cells expressed the various proteolytic enzymes, especially MMP-9 in granulation surrounding cartilage tissue and MMP-3 in both granulation and cartilage. MMP-9 is a major secretion product expressed from stimulated polymorphonuclear leukocytes and macrophages, and the active form of this gelatinase cleaves denatured collagens, fibronectin, elastin, and collagens of types IV, V, VII, and XI and is inhibited by tissue inhibitor of metalloproteinase-124. High levels of MMP-9 have been detected in human rheumatoid synovial fluid, and MMP-9 was remarkably highly expressed in the synoviocytes of the lining layer and in macrophages in inflamed synovial tissue25. MMP-9 was considered to have a strong capacity to degrade the extracellular matrix of the articular cartilage in RA25. From strong expression of MMP-9 in macrophages and neutrophils within the perichondral granulation in this study, we consider that MMP-9 may participate in the destruction of cartilage not only in RA but also in RP. MMP3 causes deterioration in a wide variety of connective tissues and plasma protein substrates, including proteoglycan; collagen of types IV, V, VII, IX; and denatured type I collagen, laminin, fibronectin, elastin, α1-proteinase inhibitor, immunoglobulin, and substance P. In addition, it has a significant function in the multienzyme cascade involved in activating procollagenase. It is well known that MMP-3 is present in RA cartilage and plays a role in joint destruction. We demonstrated that MMP-3 was very strongly expressed in the chondrocytes of deteriorated cartilage in RP. Thus, MMP-3 appears to be one of the potent proteolytic enzymes produced by the chondrocytes themselves in cartilaginous destruction in RP. MMP-1 and cathepsin D were also expressed but less strongly so in the granulation tissue, whereas cathepsin K and cathepsin L were expressed in the chondrocytes.

In this study, the cysteine proteases, cathepsin K and cathepsin L, were the most strongly expressed, together with MMP, and were positive in chondrocytes and perichondral granulation tissue. Cathepsin K cleaves the native type I and type II collagens close to the N-terminus of its triple helix26. Cathepsin L shows very high activity among all cysteine proteinases. Cathepsins K and L are abundantly produced from osteoclasts and osteoclast-like cells, and may participate in osteoclast-mediated bone resorption in RA. Our results suggest that cathepsins K and L are involved in cartilage destruction in RP.

There were many kinds of cells that were positive for LCA antibody, but it is difficult to discriminate between cell species and characterization without employing immunohistochemical methods. Neutrophilic granules contain many kinds of proteolytic enzymes such as elastase, cathepsin G, nonspecific collagenase, and lysozyme. Elastase is a basic serine protease with a molecular weight of about 30 kDa27; it has an elastolytic activity with a broad substrate specificity, and digests most proteins. We demonstrated immunohistochemically that elastase-positive cells were present in perichondral granulation tissue. There were many cases in which fairly large numbers of neutrophils infiltrated around the degenerated cartilage. In those cases elastase was significantly expressed in the neutrophils within the granulation tissue surrounding the cartilage. Our results indicated that elastase plays a major role in cartilage destruction in the early stage. Therefore, cartilage destruction may proceed in the early stage as well as in the chronic stage.

The TUNEL assay is relatively specific for apoptosis associated with determination of cell death. The apoptotic phenomenon in chondrocytes has been noted in polychondritis and OA, well known as a degenerative disease of cartilage28. These results suggest cartilage destruction is induced not only by inflammatory perichondral granulation tissue but also by intrinsic factors in chondrocytes. Generally, apoptosis of chondrocytes is a complex process induced by many factors in autoimmunity and other related diseases such as arteritis, Hashimoto’s disease29, ulcerative colitis30, and myelodysplastic disease22. In OA, a large amount of NO serves as a powerful initiator of chondrocyte apoptosis. NO has been implicated in inhibition of neosyn-thesis of matrix macromolecules of cartilage such as aggrecan through enhancing MMP activity, and in destruction of interleukin 1 (IL-1) receptor antagonist synthesis31. Our data revealed a strong positive correlation between numbers of apoptotic cells and numbers of both MMP-3-expressing cells and cathepsin K-expressing cells, suggesting that some interrelationship may be present between apoptosis and the expression of proteolytic enzymes. Experimentally, proteoglycan degradation by ceramide in rabbit cartilage is inhibited by MMP inhibitor32, and MMP is induced by IL-1-mediated NO in chondrocytes33. Further questions remain concerning the mechanisms of factors leading chondrocytes to apoptosis in RP.

  • Accepted for publication November 24, 2010.

REFERENCES

  1. 1.↵
    1. McAdam LP,
    2. O’Hanlan MA,
    3. Bluestone R,
    4. Pearson CM
    . Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore) 1976;55:193–215.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Hoang-Xaun T,
    2. Foster CS,
    3. Rice BA
    . Scleritis in relapsing polychondritis. Response to therapy. Ophthalmology 1990;97:892–8.
    OpenUrlPubMed
  3. 3.↵
    1. Van Decker W,
    2. Panidis IP
    . Relapsing polychondritis and cardiac valvular involvement. Ann Intern Med 1988;109:340–1.
    OpenUrlPubMed
  4. 4.↵
    1. Kimura Y,
    2. Miwa H,
    3. Furukawa M,
    4. Mizukami Y
    . Relapsing polychondritis presented as inner ear involvement. J Laryngol Otol 1996;110:154–7.
    OpenUrlPubMed
  5. 5.↵
    1. McCaffrey TV,
    2. McDonald TJ,
    3. McCaffrey LA
    . Head and neck manifestations of relapsing polychondritis: review of 29 cases. Otolaryngology 1978;86:473–8.
    OpenUrl
  6. 6.↵
    1. Rogerson ME,
    2. Higgins EM,
    3. Godfrey RC
    . Tracheal stenosis due to relapsing polychondritis in rheumatoid arthritis. Thorax 1987;42:905–6.
    OpenUrlFREE Full Text
  7. 7.↵
    1. Casselman JW,
    2. Lemahieu SF,
    3. Peene P,
    4. Stoffels G
    . Polychondritis affecting the laryngeal cartilages: CT findings. AJR Am J Roentgenol 1988;150:355–6.
    OpenUrlPubMed
  8. 8.↵
    1. Letko E,
    2. Zafirakis P,
    3. Baltatzis S,
    4. Voudouri A,
    5. Livir-Rallatos C,
    6. Foster CS
    . Relapsing polychondritis: a clinical review. Semin Arthritis Rheum 2002;31:384–95.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Damiani JM,
    2. Levine HL
    . Relapsing polychondritis — report of ten cases. Laryngoscope 1979;89:929–46.
    OpenUrlPubMed
  10. 10.↵
    1. Lahmer T,
    2. Treiber M,
    3. von Werder A,
    4. Foerger F,
    5. Knopf A,
    6. Heemann U,
    7. et al.
    Relapsing polychondritis: An autoimmune disease with many faces. Autoimmun Rev 2010;9:540–6.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Franssen MJ,
    2. Boerbooms AM,
    3. van de Putte LB
    . Polychondritis and rheumatoid arthritis. Case report and review of the literature. Clin Rheumatol 1987;6:453–7.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Harisdangkul V,
    2. Johnson WW
    . Association between relapsing polychondritis and systemic lupus erythematosus. South Med J 1994;87:753–7.
    OpenUrlPubMed
  13. 13.↵
    1. Zeuner M,
    2. Straub RH,
    3. Schlosser U,
    4. Rauh G,
    5. Schmitz G,
    6. Scholmerich J,
    7. et al.
    Anti-phospholipid-antibodies in patients with relapsing polychondritis. Lupus 1998;7:12–4.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Harada M,
    2. Yoshida H,
    3. Mimura Y,
    4. Ohishi M,
    5. Miyazima I,
    6. Ichikawa F,
    7. et al.
    Relapsing polychondritis associated with subclinical Sjogren’s syndrome and phlegmon of the neck. Intern Med 1995;34:768–71.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Foidart JM,
    2. Abe S,
    3. Martin GR,
    4. Zizic TM,
    5. Barnett EV,
    6. Lawley TJ,
    7. et al.
    Antibodies to type II collagen in relapsing polychondritis. N Engl J Med 1978;299:1203–7.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Alsalameh S,
    2. Mollenhauer J,
    3. Scheuplein F,
    4. Stoss H,
    5. Kalden JR,
    6. Burkhardt H,
    7. et al.
    Preferential cellular and humoral immune reactivities to native and denatured collagen types IX and XI in a patient with fatal relapsing polychondritis. J Rheumatol 1993;20:1419–24.
    OpenUrlPubMed
  17. 17.↵
    1. Buckner JH,
    2. Wu JJ,
    3. Reife RA,
    4. Terato K,
    5. Eyre DR
    . Autoreactivity against matrilin-1 in a patient with relapsing polychondritis. Arthritis Rheum 2000;43:939–43.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Gunaydin I,
    2. Daikeler T,
    3. Jacki S,
    4. Mohren M,
    5. Kanz L,
    6. Kotter I
    . Articular involvement in patients with relapsing polychondritis. Rheumatol Int 1998;18:93–6.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Weber F,
    2. Kowald E,
    3. Schmuth M,
    4. Sepp N
    . Microscopic polyangiitis in a patient with relapsing polychondritis. Rheumatology 2001;40:233–5.
    OpenUrlFREE Full Text
  20. 20.↵
    1. Matoba A,
    2. Plager S,
    3. Barber J,
    4. McCulley JP
    . Keratitis in relapsing polychondritis. Ann Ophthalmol 1984;16:367–70.
    OpenUrlPubMed
  21. 21.↵
    1. Lang-Lazdunski L,
    2. Hvass U,
    3. Paillole C,
    4. Pansard Y,
    5. Langlois J
    . Cardiac valve replacement in relapsing polychondritis. A review. J Heart Valve Dis 1995;4:227–35.
    OpenUrlPubMed
  22. 22.↵
    1. Piette JC,
    2. Papo T,
    3. Chavanon P,
    4. Huong DL,
    5. Frances C,
    6. Godeau P
    . Myelodysplasia and relapsing polychondritis. J Rheumatol 1995;22:1208–9.
    OpenUrlPubMed
  23. 23.↵
    1. Kanou A,
    2. Akimoto T,
    3. Kobayashi S,
    4. Tomita M,
    5. Tamura N,
    6. Kawano T,
    7. et al.
    Relapsing polychondritis: a case with respiratory failure [Japanese]. Nihon Rinsho Meneki Gakkai Kaishi 1997;20:52–9.
    OpenUrlPubMed
  24. 24.↵
    1. Ram M,
    2. Sherer Y,
    3. Shoenfeld Y
    . Matrix metalloproteinase-9 and autoimmune diseases. J Clin Immunol 2006;26:299–307.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Seki M,
    2. Uzuki M,
    3. Ohmoto H,
    4. Yoshino K,
    5. Maeda S,
    6. Kokubun S,
    7. et al.
    Matrix metalloproteinase (MMP-9) in patients with rheumatoid arthritis [Japanese]. Ryumachi 1995;35:792–801.
    OpenUrlPubMed
  26. 26.↵
    1. Kafienah W,
    2. Bromme D,
    3. Buttle DJ,
    4. Croucher LJ,
    5. Hollander AP
    . Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem J 1998;331:727–32.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Sinha S,
    2. Watorek W,
    3. Karr S,
    4. Giles J,
    5. Bode W,
    6. Travis J
    . Primary structure of human neutrophil elastase. Proc Natl Acad Sci USA 1987;84:2228–32.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Del Carlo M Jr.,
    2. Loeser RF
    . Cell death in osteoarthritis. Curr Rheumatol Rep 2008;10:37–42.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Kung AW,
    2. Lau CS,
    3. Wu PC
    . Graves’ ophthalmopathy and relapsing polychondritis. Clin Exp Rheumatol 1995;13:501–3.
    OpenUrlPubMed
  30. 30.↵
    1. Ueno Y,
    2. Chia D,
    3. Barnett EV
    . Relapsing polychondritis associated with ulcerative colitis. Serial determinations of antibodies to cartilage and circulating immune complexes by three assays. J Rheumatol 1981;8:456–61.
    OpenUrlPubMed
  31. 31.↵
    1. Vuolteenaho K,
    2. Moilanen T,
    3. Knowles RG,
    4. Moilanen E
    . The role of nitric oxide in osteoarthritis. Scand J Rheumatol 2007;36:247–58.
    OpenUrlPubMed
  32. 32.↵
    1. Adams CS,
    2. Horton WE Jr.
    . Chondrocyte apoptosis increases with age in the articular cartilage of adult animals. Anat Rec 1998;250:418–25.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Blanco FJ,
    2. Ochs RL,
    3. Schwarz H,
    4. Lotz M
    . Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 1995;146:75–85.
    OpenUrlPubMed
View Abstract
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 38, Issue 4
1 Apr 2011
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cartilage Destruction Is Partly Induced by the Internal Proteolytic Enzymes and Apoptotic Phenomenon of Chondrocytes in Relapsing Polychondritis
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cartilage Destruction Is Partly Induced by the Internal Proteolytic Enzymes and Apoptotic Phenomenon of Chondrocytes in Relapsing Polychondritis
NAOHISA OUCHI, MIWA UZUKI, AKIHISA KAMATAKI, YASUHIRO MIURA, TAKASHI SAWAI
The Journal of Rheumatology Apr 2011, 38 (4) 730-737; DOI: 10.3899/jrheum.101044

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Cartilage Destruction Is Partly Induced by the Internal Proteolytic Enzymes and Apoptotic Phenomenon of Chondrocytes in Relapsing Polychondritis
NAOHISA OUCHI, MIWA UZUKI, AKIHISA KAMATAKI, YASUHIRO MIURA, TAKASHI SAWAI
The Journal of Rheumatology Apr 2011, 38 (4) 730-737; DOI: 10.3899/jrheum.101044
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Save to my folders

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Salivary Gland Focus Score Is Associated With Myocardial Fibrosis in Primary Sjögren Syndrome Assessed by a Cardiac Magnetic Resonance Approach
  • Hydroxychloroquine Suppresses Interferon-inducible Genes and B Cell Activating Factor in Patients With Incomplete and New-onset Systemic Lupus Erythematosus
  • The Prevalence of Rheumatoid Arthritis: A Systematic Review of Population-based Studies
Show more Articles

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2016 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire